Related Experiment Video
Updated: Jun 2, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases
1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 210029 Nanjing, China.
Abstract:
SOX11 is mainly correlated with embryo neurogenesis and remodeling of tissues. D cyclins (cyclin D1, cyclin D2, and cyclin D3) work in cell transformation. We assessed the expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 mRNA in 152 patients with B-cell lymphocytic proliferative diseases (B-LPD) using qRT-PCR and we detected SOX11 protein using immunohistochemistry in 15 B-LPD patients, to clarify the clinical significance of the four genes in B-LPD. Data showed the transcriptional levels of SOX11 and cyclin D1 were higher for the mantle cell lymphoma (MCL) samples compared with chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), hairy cell leukemia (HCL), splenic marginal zone lymphoma (SMZL), and healthy collators. The expression levels of cyclin D1 and cyclin D2 were both higher in DLBCL than in SMZL. The expression levels of the four genes were highly related to each other. Three of 4 MCL patients showed nuclear staining for SOX11, while other 11 B-LPD examples were negative. Furthermore, we also found the ZAP70-positive CLL patients had higher SOX11 expression levels than ZAP70-negative CLL patients. It was revealed that MCL patients have higher expression levels of SOX11 and cyclin D1 mRNA, specially expressed nuclear SOX11 protein.
Insights
SOX11 and cyclin D1 mRNA expression is elevated in mantle cell lymphoma (MCL) compared to other B-cell lymphocytic proliferative diseases (B-LPD). Nuclear SOX11 protein was specifically detected in MCL patients.
Area of Science:
- Molecular Biology
- Oncology
- Hematology
Background:
- SOX11 is involved in neurogenesis and tissue remodeling.
- D cyclins (cyclin D1, D2, D3) are implicated in cell transformation.
- The role of SOX11 and D cyclins in B-cell lymphocytic proliferative diseases (B-LPD) requires further clarification.
Purpose of the Study:
- To assess the expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 mRNA and SOX11 protein in B-LPD.
- To clarify the clinical significance of these genes in B-LPD.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for mRNA expression analysis.
- Immunohistochemistry for SOX11 protein detection.
- Analysis of 152 B-LPD patients for mRNA and 15 for protein.
Main Results:
- SOX11 and cyclin D1 mRNA levels were higher in mantle cell lymphoma (MCL) than in chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), hairy cell leukemia (HCL), splenic marginal zone lymphoma (SMZL), and healthy controls.
- Cyclin D1 and cyclin D2 mRNA levels were higher in DLBCL than in SMZL.
- Nuclear SOX11 protein was detected in 3 out of 4 MCL patients, but not in other B-LPDs. ZAP70-positive CLL patients showed higher SOX11 expression than ZAP70-negative patients.
Conclusions:
- Mantle cell lymphoma (MCL) patients exhibit higher SOX11 and cyclin D1 mRNA expression.
- Nuclear SOX11 protein expression is a potential biomarker for MCL.
- SOX11 and D cyclins show significant correlations in B-LPD, suggesting a role in disease pathogenesis.
Related Concept Videos
Positive Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

